Old, legacy or MDR/IVDR device? How to tell which EUDAMED rules apply to each product before the 28 November 2026 deadline.
Explore Obelis Group’s European authorized representative services, EUDAMED registration services and more to ensure compliance for all devices!
Legacy Devices and the 28 November 2026 Deadline
By 28 November 2026, devices that were already on the EU market before 28 May 2026 and are still being placed on the market must be registered in the EUDAMED UDI/Device module.
Many manufacturers deliberate which of their products are actually legacy devices. The answer decides how a device is identified in EUDAMED, which transitional deadline applies to it. Determining whether a device qualifies as a legacy device is important, as this status affects how the device is identified in EUDAMED, applicable registration requirements, as well as the transitional deadlines that apply.
Obelis explains how legacy devices are defined, how they differ from “old” devices and MDR/IVDR devices, and what the EUDAMED registration obligation means for each of them.
What Is a Legacy Device?
Legacy devices are medical devices, active implantable medical devices and in vitro diagnostic medical devices that continue to be placed on the market after the date of application of the MDR (26 May 2021) or the IVDR (26 May 2022), under the transitional provisions of Article 120 MDR or Article 110 IVDR.
A device can be a legacy device in two situations:
- It is covered by a Directive certificate. The device holds a notified body certificate issued under Medical Device Directive 93/42/EEC (MDD), Active Implantable Medical Devices Directive 90/385/EEC (AIMDD) or In vitro Diagnostic Device Directive 98/79/EC (IVDD), and that certificate remains valid under the extended transitional rules.
- It was self-declared under the Directives but needs a notified body under the new Regulations. This applies where the declaration of conformity was drawn up before 26 May 2021 under the MDD or before 26 May 2022 under the IVDD, and the conformity assessment procedure under the Regulations requires the involvement of a notified body. Typical examples are MDD class I devices that are up-classified under the MDR, MDD class I reusable surgical instruments, which remain class I under the MDR but need a notified body for their reprocessing aspects; and IVDs that were self-declared under the IVDD but are classified as class B, C, D or class A sterile under the IVDR.
Devices that remain self-declared under the new rules, such as non-sterile class I medical devices without a measuring function or non-sterile class A IVDs, are not legacy devices. They have been required to comply fully with the MDR since 26 May 2021, or with the IVDR since 26 May 2022.
Old, Legacy and Regulation Devices: Three Groups, Three Sets of Rules
Many registration mistakes start with mixing up three categories that are very different
| Category | What it means | EUDAMED UDI/Device registration |
| Old devices | Devices placed on the market under the Directives before 26 May 2021 (MDR) or 26 May 2022 (IVDR) | Cannot be registered. If a serious incident or field safety corrective action (FSCA) has to be reported, a limited set of device data will need to be provided with the relevant report via the Vigilance EUDAMED module once functional |
| Legacy devices | Devices placed on the market after 26 May 2021 (MDR) or 26 May 2022 (IVDR) under the applicable transitional provisions | Required if units are still placed on the market on or after 28 May 2026. Identified with a EUDAMED DI and EUDAMED ID or, where the device already has a UDI-DI, with that UDI-DI and a EUDAMED DI generated from it |
| Regulation devices | Devices that fully comply with the MDR or IVDR, with an MDR or IVDR notified body certificate where one is required | Required. Identified with a Basic UDI-DI and UDI-DI. New devices must be registered before their first unit is placed on the market |
Do MDD and IVDD Devices Still on the Market in 2026 Need EUDAMED Registration?
In most cases, yes. Under the rules explained in the Commission’s Q&A on the gradual roll-out of EUDAMED, a legacy device must be registered in the UDI/Device module within 12 months from the Commission’s notice declaring the functionality of the EUDAMED UDI/Devices module. The noticed was published on 27 November 2025. Accordingly, a legacy device must be registered in EUDAMED by 28 November 2026, where:
- its first unit with a given device identifier was placed on the EU market before 28 May 2026, and
- further units with the same identifier continue to be placed on the market on or after that date.
When a legacy device does not need to be registered
- It is no longer placed on the market. If no units are placed on the market from 28 May 2026, the device does not need to be registered, unless a post-market surveillance or vigilance action occurs and has to be reported in EUDAMED once the Vigilance module becomes mandatory.
- “The same device” is already registered as a Regulation device. If the MDR or IVDR version shares the UDI-DI the legacy version does not need its own registration. If changes made for the MDR or IVDR version required a new UDI-DI, the two are no longer considered “the same device”.
Once the Vigilance module is live, if a serious incident report, FSCA or trend report concerns the legacy device rather than its Regulation counterpart, the legacy device must be registered so that the report can refer to it.
How Legacy Devices Are Identified in EUDAMED
Legacy devices are identified with a EUDAMED DI, EUDAMED ID or a UDI-DI the device already carries. The manufacturer also enters the details of the Directive certificate, and non-EU manufacturers need an EU Authorised Representative with an active mandate in EUDAMED.
Our separate article on registering legacy devices without a Basic UDI-DI explains both identification routes step by step, and our overview of common legacy device registration mistakes shows what to check before you submit.
What About the MDR and IVDR Revision?
In December 2025, the European Commission published a proposal for a targeted revision of the MDR and IVDR. It would allow certain legacy devices recognised as orphan devices to remain on the market beyond the current transitional deadlines, subject to conditions.
The proposal is still going through the legislative procedure in the European Parliament and the Council. Until it is adopted and enters into force, the current transitional periods and the 28 November 2026 EUDAMED deadline apply unchanged.
How Obelis Can Help
Correctly classifying a mixed portfolio of old, legacy and Regulation devices is the first step towards an accurate EUDAMED registration, and the one where mistakes are hardest to spot later.
As your EU Authorised Representative, Obelis can support you with:
- reviewing your Directive certificates and transitional conditions to confirm which devices qualify as legacy devices;
- identifying which legacy devices must be registered by 28 November 2026 and which are exempt;
- preparing identification data for legacy devices and linking them to their MDR or IVDR successors;
- completing your EUDAMED registration and keeping it up to date.
Sources
- European Union (2017). Regulation (EU) 2017/745 on medical devices, consolidated version. EUR-Lex. Retrieved on 2 November 2026 from https://eur-lex.europa.eu/eli/reg/2017/745
- European Union (2017). Regulation (EU) 2017/746 on in vitro diagnostic medical devices, consolidated version. EUR-Lex. Retrieved on 2 November 2026 from https://eur-lex.europa.eu/eli/reg/2017/746
- European Union (2023). Regulation (EU) 2023/607 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices. EUR-Lex. Retrieved on 2 November 2026 from https://eur-lex.europa.eu/eli/reg/2023/607/oj
- European Union (2024). Regulation (EU) 2024/1860 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices. EUR-Lex. Retrieved on 2 November 2026 from https://eur-lex.europa.eu/eli/reg/2024/1860/oj
- Medical Device Coordination Group (2024). MDCG 2021-25 Rev. 1 – Application of MDR requirements to “legacy devices” and to devices placed on the market prior to 26 May 2021. Retrieved on 2 November 2026 from https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
- Medical Device Coordination Group (2022). MDCG 2022-8 https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
- European Commission (2024). Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860. Retrieved on 2 November 2026 from https://health.ec.europa.eu/latest-updates/gradual-roll-out-eudamed-qas-practical-aspects-related-implementation-regulation-eu-20241860-2024-11-21_en
- European Commission (2025). Proposal for a Regulation amending Regulations (EU) 2017/745 and (EU) 2017/746, COM(2025) 1023 final. Retrieved on 2 November 2026 from https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:52025PC1023
Compliance Insights You Might Find Interesting
- Cosmetic/ hair care product classification tips
- Chemical and mineral sunscreen EU rules of 2026
- Health Canada cosmetic notification form updates in 2026
- All about pao for cosmetics in the EU
- EU fragrance allergen list requirements
- The homosalate EU regulation of 2025
- The general product safety regulation 2024
Leave a Reply